PEREZ IGNACIO DIAZ is an academic who is affiliated with AstraZeneca Argentina MC and who published a paper in 2018 entitled BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population.